This allows quicker access to maximum efficacy but may produce more intense initial side effects
Clinical results: The SURMOUNT-1 trial, published in the New England Journal of Medicine, showed tirzepatide produced average weight loss of 20.9 percent at the 15 mg dose
However, these personal stories dont tell the whole story and dont always reflect safe or effective use
Neuropathic pain, on the other hand, tends to be chronic and less sharp
Storage comparison: retatrutide vs other GLP-1 peptides If you have experience storing other peptides, understanding how retatrutide compares helps you calibrate your expectations and apply existing knowledge
Downsides of Rapid Weight Loss In addition to potential side effects from the medication, its important to consider the implications of rapid weight loss